查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2122035

醫療保健印刷電子產品：市場佔有率分析、行業趨勢和統計數據以及成長預測（2026-2031 年）

Printed Electronics In Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

據 Mordor Intelligence 稱，2025 年醫療保健印刷電子市場價值為 24.1 億美元，預計到 2031 年將從 2026 年的 27.4 億美元成長至 52 億美元，預測期（2026-2031 年）的複合年成長率為 13.67%。

醫療保健領域的印刷電子產品市場-IMG1

本報告按類型（印刷生物感測器、印刷生理感測器、印刷RFID/NFC標籤等）、印刷技術（網版印刷、噴墨印刷等）、應用（病患監測、診斷測試、藥物傳輸等）、最終用戶（醫院、居家醫療等）和地區進行細分。市場預測以價值（美元）表示。

全球醫療保健印刷電子市場趨勢與洞察

美國居家醫療領域用於遠端患者監護的穿戴式貼片迅速普及。

遠端醫療醫療保險（Medicare）擴大了遠距醫療的報銷範圍，加上美國食品藥物管理局（FDA）批准了親膚型血糖值和心電圖貼片，正在加速印刷感測器在居家醫療領域的廣泛應用。採用微流體控技術的混合貼片現在可以測量多種生命徵象，為醫療團隊提供詳細的時間序列數據，無需患者前往診所。美國醫療保健系統報告稱，再入院率降低，患者滿意度提高，切實節省了成本。在這種環境下拓展業務的設備製造商，正在為歐盟和亞太地區的醫療保健系統評估其報銷框架樹立令人信服的先例。

歐盟反仿冒藥品指令推廣採用印有RFID技術的智慧藥品包裝。

歐盟《反仿冒藥品指令》要求藥品生產商在所有零售包裝中加入防偽功能，以實現藥品的全面序列化。如今，採用高速柔版印刷生產線生產的印刷RFID和NFC標籤，能夠以可接受的成本滿足學名藥和品牌藥生產商的追溯性和防篡改要求。採用符合歐盟標準的包裝的全球製藥公司正在將類似的解決方案推廣到亞太地區的物流中心，從而催生了對適用於紙張和箔材的導電油墨的協同需求。

FDA和EMA的檢驗週期延緩了商業化進程。

由於評審人員要求提供新材料的額外實驗和臨床數據，實際的510(k)評審通常遠超預期，耗時六至七個月。 De Novo分類進一步延長了核准流程，而新的歐洲醫療設備法規（MDR）強制要求進行額外的臨床性能測試，導致需要重複申請。網路安全和人工智慧方面更嚴格的文件要求進一步增加了測試成本，迫使一些中型公司推遲在美國的上市計劃，轉而優先在中東和非洲（MEA）以及南美洲進行試點部署。

細分市場分析

到2025年，印刷生物感測器將佔印刷電子市場41.35%的佔有率。血糖值試紙和連續血糖監測儀將成為應用最廣泛的產品，這得益於美國非處方藥（OTC）的批准，這些藥物有助於消除人們對常規血糖監測的偏見。傳染病檢查仍將是亞太地區公共衛生相關競標的主要驅動力，而新興的pH測量貼片和傷口監測貼片正在拓展其臨床應用。

兼具可拉伸性和柔軟性的混合電子產品預計將以16.02%的複合年成長率成長，成為所有類型產品中成長最快的。自修復導電網狀材料已能夠承受反覆的應變循環而不發生分層，從而實現對心臟和神經長達一周的監測。用於藥品包裝的印刷型RFID標籤是第二大需求支柱，尤其是在全球序列化法規日益完善的情況下。

網版印刷憑藉其成熟的加工能力和低成本的一次性電極，預計到 2025 年將佔印刷電子市場 52.25% 的佔有率。成熟的製程控制有助於獲得 FDA 批准，使其成為大規模生產生物感測器的標準技術。

氣溶膠噴射和3D成型技術正以14.46%的複合年成長率成長。這項技術能夠在微流體通道內形成導電軌道，將原型製作時間從數天縮短至數分鐘。瑞士和新加坡的早期採用者已在試點規模上實現了亞100微米的通道精度，從而能夠快速迭代實驗室晶片診斷設備的設計。

區域分析

預計到2025年，北美將佔全球銷售額的40.15%。這部分歸功於美國食品藥物管理局（FDA）早期推出的數位健康框架以及美國國立衛生研究院（NIH）為降低材料研發風險提供的資金支持。梅奧診所和克利夫蘭診所的多中心試驗正在檢驗遠端監測終點，並促進區域醫院網路的採購核准。位於安大略省的加拿大研究叢集正在帶來基板知識，並進一步鞏固其在北美的領先地位。

歐洲仍然是一個具有重要戰略意義的地區。該地區的主要製藥公司必須遵守“假藥指令”，這鞏固了對序列化智慧標籤的持續需求。德國精密機械製造的傳統促進了大規模印刷機的普及，而在英國，創業投資資金正湧入軟性積體電路新創公司。法國和北歐國家的公共衛生部門正在透過預防性醫療保健保險來推廣遠端感測器的應用。

預計中東和非洲地區將以15.16%的複合年成長率成為全球成長最快的地區。在沙烏地阿拉伯和阿拉伯聯合大公國（阿拉伯聯合大公國），隨著國家醫療保健體系的擴展，政府正在為聯網診斷設備分配預算，印刷電子技術也日益受到關注，因為它無需大規模基礎設施建設即可快速向農村地區提供醫療保健服務。南非的監管機構正在使醫療設備分類標準與美國食品藥物管理局（FDA）的分類標準保持一致，並加快進口核准流程。這一趨勢表明，該地區的醫療技術正朝著自給自足的方向顯著轉變。

其他好處：

  • Excel格式的市場預測（ME）表
  • 3個月的分析師支持

目錄

第1章：引言

  • 研究假設和市場定義
  • 調查範圍

第2章：調查方法

第3章執行摘要

第4章 市場狀況

  • 市場概覽
  • 市場促進因素
    • 在美國，用於遠端患者監護的穿戴式貼片在居家照護領域迅速普及。
    • 歐盟的反仿冒藥品指令是否正在推動RFID列印智慧藥品包裝的普及？
    • 亞洲一次性即時檢測生物感測器在感染疾病檢測領域需求激增
    • 慢性疾病的負擔推動了循環系統領域對軟性印刷電極的需求。
    • 疫苗需要使用印刷式溫度感測器來增強冷鏈的完整性。
    • 美國國立衛生研究院和歐盟地平線計畫資助了生物相容性導電油墨的研究和開發；
  • 市場限制因素
    • FDA 和 EMA 的核准審查流程正在推遲商業化的開始。
    • 聚合物基材的滅菌和生物相容性的挑戰
    • 濕度引起的劣化限制了印刷生物感測器的保存期限。
    • 新興市場對穿戴式診斷設備的報銷存在不確定性。
  • 產業生態系分析
  • 監管和技術展望
    • 印刷技術概述
      • 網版印刷
      • 噴墨列印
      • 凹版印刷及柔版印刷
      • 氣溶膠噴射和其他新興技術
  • 波特五力分析

第5章 市場規模與成長預測

  • 按類型
    • 印刷生物感測器
      • 葡萄糖感測器
      • 感染疾病檢測條
      • 其他生物感測器
    • 印刷式生理感測器
      • 心電圖（ECG）/腦電圖（EEG）電極
      • 溫度和 pH 值貼片
    • 可列印的RFID/NFC標籤
    • 可拉伸軟性混合電子裝置
    • 印刷微流體技術
    • 其他印刷組件（天線、加熱器）
  • 透過印刷技術
    • 網版印刷
    • 噴墨列印
    • 凹版/柔版
    • 氣溶膠噴射和3D列印
  • 透過使用
    • 病患監測和穿戴式設備
    • 診斷檢測和即時檢測
    • 藥物傳輸和智慧型貼片
    • 藥品包裝和防偽措施
    • 醫療影像和治療設備
    • 其他
  • 最終用戶
    • 醫院和診所
    • 家庭醫療保健服務提供者
    • 製藥和生物技術公司
    • 診斷檢查室
    • 學術研究機構
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 北歐的
      • 其他歐洲國家
    • 南美洲
      • 巴西
      • 其他南美國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 東南亞
      • 其他亞太國家
    • 中東和非洲
      • 中東
        • 波灣合作理事會（GCC）成員國
        • 土耳其
        • 其他中東國家
      • 非洲
        • 南非
        • 其他非洲國家

第6章 競爭情勢

  • 市場集中度
  • 策略趨勢
  • 市佔率分析
  • 公司簡介
    • DuPont de Nemours, Inc.
    • Henkel AG and Co. KGaA
    • Nissha Co., Ltd.（Nissha Medical）
    • Flex Ltd.（Health Solutions）
    • Molex LLC（Sensable）
    • GE Healthcare
    • Abbott Laboratories（FreeStyle Libre Sensors）
    • Medtronic plc（Printed Electrodes）
    • Jabil Inc.（Blue Sky Center）
    • Zimmer Biomet（Smart Implants）
    • NovaCentrix Corp.
    • PragmatIC Semiconductor Ltd.
    • Thinfilm Electronics ASA
    • Toppan Printing Co., Ltd.（Healthcare Labels）
    • PolyIC GmbH and Co. KG
    • GSI Technologies LLC
    • PV Nano Cell Ltd.
    • Coatema Coating Machinery GmbH
    • Bebop Sensors Inc.
    • Sensing Tex SL

第7章 市場機會與未來展望

簡介目錄
Product Code: 56747

According to Mordor Intelligence, the printed electronics market size in healthcare was valued at USD 2.41 billion in 2025 and estimated to grow from USD 2.74 billion in 2026 to reach USD 5.2 billion by 2031, at a CAGR of 13.67% during the forecast period (2026-2031).

Printed Electronics In Healthcare - Market - IMG1

This report is Segmented by Type (Printed Biosensors, Printed Physiological Sensors, Printed RFID/NFC Labels, and More), Printing Technology (Screen Printing, Inkjet Printing, and More), Application (Patient Monitoring, Diagnostic Testing, Drug Delivery, and More), End-User (Hospitals, Home Healthcare, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Printed Electronics In Healthcare Market Trends and Insights

Rapid Uptake of Remote Patient-Monitoring Wearable Patches in United States Homecare

Medicare's broader reimbursement for telehealth, coupled with FDA clearance of skin-friendly glucose and cardiac patches, fuels wide deployment of printed sensors in the home-care channel. Hybrid microfluidic-regulated patches now capture multi-parameter vitals, handing care teams granular longitudinal data without clinic visits. U.S. systems report fewer readmissions and higher patient satisfaction, confirming tangible cost savings. Device makers scaling in this environment set a compelling precedent for EU and APAC health systems as they evaluate reimbursement frameworks.

EU Falsified Medicines Directive Catalyzing Smart Pharma-Packaging with Printed RFID

Full serialization under the EU Falsified Medicines Directive forces pharmaceutical producers to embed authentication features on every retail pack. Printed RFID and NFC tags, fabricated on high-speed flexographic lines, now satisfy both traceability and tamper evidence at unit cost levels acceptable to generic and branded manufacturers. Global drug firms adopting EU-compliant packaging extend the same solutions to APAC logistics hubs, creating a multiplier effect on demand for conductive inks optimized for paper and foil substrates.

FDA and EMA Validation Cycles Delaying Commercial Roll-outs

Actual 510(k) reviews often stretch to 6-7 months, well beyond nominal timelines, as examiners request extra bench and clinical data on novel substrates. De novo classifications lengthen approvals further, and the new European MDR imposes additional clinical performance studies, forcing dual submission tracks. Rising cybersecurity and AI documentation requirements add layers of testing cost, prompting some mid-cap firms to defer U.S. launches in favor of pilot deployments in MEA or South America.

Other drivers and restraints analyzed in the detailed report include:

  1. Surge in Point-of-Care Disposable Biosensors for Infectious Disease Detection in Asia
  2. Cold-Chain Integrity Needs Boosting Printed Temperature Sensors for Vaccines
  3. Sterilization and Biocompatibility Challenges of Polymer Substrates

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Printed biosensors held 41.35% of the printed electronics market in 2025. Glucose strips and continuous glucose monitors dominate the installed base, buoyed by over-the-counter U.S. approvals that destigmatize routine monitoring. Infectious disease assays remain a growth engine in APAC public-health tenders, while emerging pH and wound-monitor patches broaden clinical reach.

Stretchable and flexible hybrid electronics is projected to post a 16.02% CAGR, the fastest among types. Self-healing conductive meshes now survive repeated strain cycles without delamination, allowing week-long cardiac or neuro monitoring. Printed RFID labels for pharma packs add a second demand pillar, especially as global serialization mandates mature

Screen printing captured 52.25% of the printed electronics market in 2025 thanks to proven throughput and low per-unit costs for disposable electrodes. Mature process controls ease FDA filing, making it the default for high-volume biosensors.

Aerosol jet and 3D methods are growing at a 14.46% CAGR. Their ability to deposit conductive tracks inside 3D microfluidic channels has cut prototyping times from days to minutes. Early adopters in Switzerland and Singapore have demonstrated sub-100 µm channel fidelity at pilot scale, enabling rapid design iteration for lab-on-chip diagnostics.

Complete Report Scope:

  • By Type
    • Printed Biosensors
      • Glucose Sensors
      • Infectious-Disease Test Strips
      • Other Biosensors
    • Printed Physiological Sensors
      • ECG/EEG Electrodes
      • Temperature/pH Patches
    • Printed RFID/NFC Labels
    • Stretchable and Flexible Hybrid Electronics
    • Printed Microfluidics
    • Other Printed Components (Antennas, Heaters)
  • By Printing Technology
    • Screen Printing
    • Inkjet Printing
    • Gravure/Flexography
    • Aerosol Jet and 3D Printing
  • By Application
    • Patient Monitoring and Wearables
    • Diagnostic Testing and Point-of-Care
    • Drug Delivery and Smart Patches
    • Pharmaceutical Packaging and Anti-Counterfeit
    • Medical Imaging and Therapeutic Devices
    • Others
  • By End-user
    • Hospitals and Clinics
    • Home Healthcare Providers
    • Pharmaceutical and Biotech Companies
    • Diagnostic Laboratories
    • Academic and Research Institutes
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Nordics
      • Rest of Europe
    • South America
      • Brazil
      • Rest of South America
    • Asia-Pacific
      • China
      • Japan
      • India
      • South-East Asia
      • Rest of Asia-Pacific
    • Middle East and Africa
      • Middle East
        • Gulf Cooperation Council Countries
        • Turkey
        • Rest of Middle East
      • Africa
        • South Africa
        • Rest of Africa

Geography Analysis

North America posted 40.15% of global revenue in 2025, benefiting from FDA's early digital-health frameworks and NIH funding streams that de-risk material R&D. Multicenter trials at Mayo Clinic and Cleveland Clinic validate remote monitoring endpoints, smoothing procurement approvals for regional hospital networks. Canadian research clusters in Ontario add specialized substrate expertise, further bolstering continental leadership.

Europe remains a strategic stronghold. The region's pharmaceutical giants must comply with the Falsified Medicines Directive, locking in sustained demand for serialized smart tags. Germany's precision-machinery heritage supports high-volume printing presses, while the United Kingdom channels venture funding into flexible IC startups. Public health authorities in France and Nordic nations augment uptake through preventive-care reimbursement for remote sensors.

The Middle East and Africa is forecast to deliver a 15.16% CAGR, the fastest worldwide. National health expansions in Saudi Arabia and the United Arab Emirates allocate budget lines for connected diagnostics, seeing printed electronics as a quick path to rural coverage without heavy infrastructure. South Africa's regulatory agency aligns its device code to FDA classification, accelerating import approvals. This momentum signals a step-change in the region's medical technology self-sufficiency.

  1. DuPont de Nemours, Inc.
  2. Henkel AG and Co. KGaA
  3. Nissha Co., Ltd. (Nissha Medical)
  4. Flex Ltd. (Health Solutions)
  5. Molex LLC (Sensable)
  6. GE Healthcare
  7. Abbott Laboratories (FreeStyle Libre Sensors)
  8. Medtronic plc (Printed Electrodes)
  9. Jabil Inc. (Blue Sky Center)
  10. Zimmer Biomet (Smart Implants)
  11. NovaCentrix Corp.
  12. PragmatIC Semiconductor Ltd.
  13. Thinfilm Electronics ASA
  14. Toppan Printing Co., Ltd. (Healthcare Labels)
  15. PolyIC GmbH and Co. KG
  16. GSI Technologies LLC
  17. PV Nano Cell Ltd.
  18. Coatema Coating Machinery GmbH
  19. Bebop Sensors Inc.
  20. Sensing Tex S.L.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Uptake of Remote Patient-Monitoring Wearable Patches in United States Homecare
    • 4.2.2 EU Falsified Medicines Directive Catalyzing Smart Pharma-Packaging with Printed RFID
    • 4.2.3 Surge in Point-of-Care Disposable Biosensors for Infectious Disease Detection in Asia
    • 4.2.4 Chronic-Disease Burden Driving Demand for Flexible Printed Electrodes in Cardiology
    • 4.2.5 Cold-Chain Integrity Needs Boosting Printed Temperature Sensors for Vaccines
    • 4.2.6 NIH and EU Horizon Grants Funding Bio-Compatible Conductive-Ink R&D
  • 4.3 Market Restraints
    • 4.3.1 FDA and EMA Validation Cycles Delaying Commercial Roll-outs
    • 4.3.2 Sterilization and Biocompatibility Challenges of Polymer Substrates
    • 4.3.3 Humidity-Driven Degradation Limiting Shelf-Life of Printed Biosensors
    • 4.3.4 Reimbursement Ambiguity for Wearable Diagnostics in Emerging Markets
  • 4.4 Industry Ecosystem Analysis
  • 4.5 Regulatory and Technological Outlook
    • 4.5.1 Printing Technology Snapshot
      • 4.5.1.1 Screen Printing
      • 4.5.1.2 Inkjet Printing
      • 4.5.1.3 Gravure and Flexography
      • 4.5.1.4 Aerosol Jet and Other Emerging Techniques
  • 4.6 Porter's Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUES)

  • 5.1 By Type
    • 5.1.1 Printed Biosensors
      • 5.1.1.1 Glucose Sensors
      • 5.1.1.2 Infectious-Disease Test Strips
      • 5.1.1.3 Other Biosensors
    • 5.1.2 Printed Physiological Sensors
      • 5.1.2.1 ECG/EEG Electrodes
      • 5.1.2.2 Temperature/pH Patches
    • 5.1.3 Printed RFID/NFC Labels
    • 5.1.4 Stretchable and Flexible Hybrid Electronics
    • 5.1.5 Printed Microfluidics
    • 5.1.6 Other Printed Components (Antennas, Heaters)
  • 5.2 By Printing Technology
    • 5.2.1 Screen Printing
    • 5.2.2 Inkjet Printing
    • 5.2.3 Gravure/Flexography
    • 5.2.4 Aerosol Jet and 3D Printing
  • 5.3 By Application
    • 5.3.1 Patient Monitoring and Wearables
    • 5.3.2 Diagnostic Testing and Point-of-Care
    • 5.3.3 Drug Delivery and Smart Patches
    • 5.3.4 Pharmaceutical Packaging and Anti-Counterfeit
    • 5.3.5 Medical Imaging and Therapeutic Devices
    • 5.3.6 Others
  • 5.4 By End-user
    • 5.4.1 Hospitals and Clinics
    • 5.4.2 Home Healthcare Providers
    • 5.4.3 Pharmaceutical and Biotech Companies
    • 5.4.4 Diagnostic Laboratories
    • 5.4.5 Academic and Research Institutes
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Nordics
      • 5.5.2.5 Rest of Europe
    • 5.5.3 South America
      • 5.5.3.1 Brazil
      • 5.5.3.2 Rest of South America
    • 5.5.4 Asia-Pacific
      • 5.5.4.1 China
      • 5.5.4.2 Japan
      • 5.5.4.3 India
      • 5.5.4.4 South-East Asia
      • 5.5.4.5 Rest of Asia-Pacific
    • 5.5.5 Middle East and Africa
      • 5.5.5.1 Middle East
        • 5.5.5.1.1 Gulf Cooperation Council Countries
        • 5.5.5.1.2 Turkey
        • 5.5.5.1.3 Rest of Middle East
      • 5.5.5.2 Africa
        • 5.5.5.2.1 South Africa
        • 5.5.5.2.2 Rest of Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 DuPont de Nemours, Inc.
    • 6.4.2 Henkel AG and Co. KGaA
    • 6.4.3 Nissha Co., Ltd. (Nissha Medical)
    • 6.4.4 Flex Ltd. (Health Solutions)
    • 6.4.5 Molex LLC (Sensable)
    • 6.4.6 GE Healthcare
    • 6.4.7 Abbott Laboratories (FreeStyle Libre Sensors)
    • 6.4.8 Medtronic plc (Printed Electrodes)
    • 6.4.9 Jabil Inc. (Blue Sky Center)
    • 6.4.10 Zimmer Biomet (Smart Implants)
    • 6.4.11 NovaCentrix Corp.
    • 6.4.12 PragmatIC Semiconductor Ltd.
    • 6.4.13 Thinfilm Electronics ASA
    • 6.4.14 Toppan Printing Co., Ltd. (Healthcare Labels)
    • 6.4.15 PolyIC GmbH and Co. KG
    • 6.4.16 GSI Technologies LLC
    • 6.4.17 PV Nano Cell Ltd.
    • 6.4.18 Coatema Coating Machinery GmbH
    • 6.4.19 Bebop Sensors Inc.
    • 6.4.20 Sensing Tex S.L.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

  • 7.1 White-space and Unmet-Need Assessment